Literature DB >> 24336298

Anterior vitreous displacement of the intravitreal dexamethasone implant (Ozurdex).

S Wai Ch'ng1, S Padroni1, S Banerjee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24336298      PMCID： PMC3930275          DOI： 10.1038/eye.2013.270

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Anterior chamber migration of dexametasone intravitreal implant (Ozurdex®).

Authors:  Diamar Pardo-López; Ester Francés-Muñoz; Roberto Gallego-Pinazo; Manuel Díaz-Llopis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-08-23       Impact factor: 3.117

2.  Vitreous traction after Ozurdex injection.

Authors:  Christoph R Clemens; Thomas Bertelmann; Carsten H Meyer
Journal:  J Ocul Pharmacol Ther       Date:  2012-10-25       Impact factor: 2.671

3.  Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant.

Authors:  Joan-En Chang-Lin; Mayssa Attar; Andrew A Acheampong; Michael R Robinson; Scott M Whitcup; Baruch D Kuppermann; Devin Welty
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

4.  Release and velocity of micronized dexamethasone implants with an intravitreal drug delivery system: kinematic analysis with a high-speed camera.

Authors:  Carsten H Meyer; Adrian Klein; Florian Alten; Zengping Liu; Boris V Stanzel; Hans M Helb; Christian K Brinkmann
Journal:  Retina       Date:  2012 Nov-Dec       Impact factor: 4.256

5.  Wandering Ozurdex(®) implant.

Authors:  Reema Bansal; Pooja Bansal; Pandurang Kulkarni; Vishali Gupta; Aman Sharma; Amod Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2011-09-30
  5 in total
  5 in total

1.  Spontaneous relocation of a trapped retrolenticular slow-release dexamethasone implant (Ozurdex) in a silicone oil-filled eye of a pseudophakic patient.

Authors:  P J Banerjee; P Petrou; T M Zvobgo; D G Charteris
Journal:  Eye (Lond)       Date:  2014-05-02       Impact factor: 3.775

2.  In vivo and in vitro sustained release of ranibizumab from a nanoporous thin-film device.

Authors:  Kevin D Lance; Daniel A Bernards; Natalie A Ciaccio; Samuel D Good; Thaís S Mendes; Max Kudisch; Elliot Chan; Mynna Ishikiriyama; Robert B Bhisitkul; Tejal A Desai
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

3.  Location of a Dexamethasone Implant at the Macula after Intravitreal Injection in a Silicone Oil-Filled Eye.

Authors:  Cenap Mahmut Esenulku; Murat Gunay
Journal:  Case Rep Ophthalmol Med       Date:  2016-11-23

4.  Anterior chamber migration of a sustained-release dexamethasone intravitreal implant: A case report and review of literature.

Authors:  Parthopratim Dutta Majumder; Amit H Palkar; Nikita Pathare; Jyotirmay Biswas
Journal:  Oman J Ophthalmol       Date:  2019 May-Aug

Review 5.  Dexamethasone intravitreal implant in the treatment of diabetic macular edema.

Authors:  Pravin U Dugel; Francesco Bandello; Anat Loewenstein
Journal:  Clin Ophthalmol       Date:  2015-07-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.